Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-792-7586
Education & Training
- Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 1996 - 1999
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1991 - 1995
- Yale School of MedicineClass of 1991
Certifications & Licensure
- FL State Medical License 2021 - 2026
- TX State Medical License 1999 - 2026
- OK State Medical License 2023 - 2025
- WA State Medical License 2022 - 2025
- AL State Medical License 2023 - 2024
- AZ State Medical License 2023 - 2024
- GA State Medical License 2023 - 2024
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer Start of enrollment: 2002 Feb 01
- RAD001 in Recurrent Endometrial Cancer Patients Start of enrollment: 2004 Jun 01
- Ovarian Cancer Patient Questionnaire on Genetic Testing Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsAssessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.Shalaka S. Hampras, Lara E. Sucheston-Campbell, Rikki Cannioto, Jenny Chang-Claude, Francesmary Modugno
Oncotarget. 2016-07-05 - 224 citationsRisk Factors for Young Premenopausal Women With Endometrial CancerPamela T. Soliman, Jonathan C. Oh, Kathleen M. Schmeler, Charlotte C. Sun, Brian M. Slomovitz
Obstetrics and Gynecology. 2005-03-01 - 84 citationsEarly Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Tw...Steven J. Skates, Mark H. Greene, Saundra S. Buys, Phuong L. Mai, Powel H. Brown
Clinical Cancer Research. 2017-07-15
Journal Articles
- Variants in Genes Encoding Small GTPases and Association with Epithelial Ovarian Cancer SusceptibilityJulie M Cunningham, Robert P Edwards, Elizabeth M Poole, Tanja Pejovic, Karen Lu, Kunle Odunsi, Beth Y Karlan, Christine S Walsh, Douglas A Levine, Andrew Berchuck, Da..., PLoS One
- KMT2D/MLL2 Inactivation Is Associated with Recurrence in Adult-Type Granulosa Cell Tumors of the OvaryR Tyler Hillman, Karen H Lu, David M Gershenson, Nature
- Systematic Identification of Druggable Epithelial–Stromal Crosstalk Signaling Networks in Ovarian CancerSamuel C Mok, Karen H Lu, Journal of the National Cancer Institute
Lectures
- Women's Health 2013: The 21st Annual CongressAcademy of Women's Health, Washington, Dist Of Col - 3/22/2013
Other
- Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)Lu KH, Schmeler KM
http://www.uptodate.com/contents/endometrial-and-ovarian-cancer-screening-and-prevention-in-women-wi
UpToDate, Wolters Kluwer Health - 2012-11-12
Press Mentions
- AACR Announces Recipients of Its 2022 Scientific Achievement Awards and LectureshipsApril 4th, 2022
- Trials Test New Approach to Hereditary Ovarian Ca Risk ReductionMarch 20th, 2019
- Scientists Detect New Ovarian Cancer TargetJune 14th, 2018
- Join now to see all
Grant Support
- Training Of Academic Gynecologic OncologistsNational Cancer Institute2011
- Metformin For The Chemoprevention Of Endometrial Cancer In Obese, Insulin-ResistaNational Cancer Institute2010–2011
- M.D. Anderson Gynecologic Spore For Uterine CancersNational Cancer Institute2010–2011
- Administrative CoreNational Cancer Institute2010–2011
- Annual Uterine Cancer Biology SymposiumNational Cancer Institute2010
- MD Anderson Cancer Ctr. Gynecology SPORE: Uterine CancerNational Cancer Institute2007–2009
- Annual Uterine Cancer SymposiumNational Cancer Institute2004–2008
- Phase II Clinical Trail - An Exploratory Study To IdentiDivision Of Cancer Prevention And Control2000
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: